Latest DEF 14A proxy statements

Brinker International's definitive proxy statement highlights exceptional fiscal 2025 financial results and outlines proposals for its upcoming November 2025 annual meeting.

VIAVI Solutions Inc. reports a return to growth in Fiscal Year 2025, driven by diversification into data center and aerospace & defense markets, alongside strategic acquisitions and capital allocation.

High Roller Technologies seeks stockholder approval to amend its equity incentive plan, increasing available shares from 1.7M to 4.2M.

Independent proxy advisory firms Glass Lewis and ISS recommend shareholders vote for Cushman & Wakefield's proposed redomiciliation to Bermuda, citing expected shareholder value creation and cost savings.

ESSA Pharma Inc. is facing a putative class action lawsuit alleging breach of contract and promissory estoppel related to disclosures made prior to its announced business combination with XenoTherapeutics Inc.

Glucotrack, Inc. calls a Special Meeting to approve the issuance of over 20% of its common stock to Sixth Borough Capital Fund, LP for a $20 million equity financing facility.

Firefly Neuroscience, Inc. will hold its Annual Meeting on October 27, 2025, seeking stockholder approval for director elections, auditor ratification, and significant increases in its equity incentive plan and total authorized shares.

GSR III Acquisition Corp. and Terra Innovatum Global S.R.L. announced additional financings totaling $35.16 million and updated beneficial ownership ahead of their business combination.

Coherent Corp. announces its 2025 Annual Meeting of Shareholders to be held on November 13, 2025, featuring director elections, executive compensation vote, and auditor ratification.

XOMA Royalty Corporation and LAVA Therapeutics N.V. announced the extension of the tender offer for LAVA's outstanding shares until October 17, 2025.

REPOSITRAK, INC. has filed Definitive Additional Materials with the SEC, indicating further proxy solicitations.

Sysco Corporation has filed a Definitive Proxy Statement (Schedule 14A) with the U.S. Securities and Exchange Commission.

Sysco Corporation announced record annual revenue of $81.4 billion for fiscal year 2025, alongside strategic initiatives aimed at accelerating profitable growth in fiscal year 2026.

Tesla is soliciting shareholder proxies for its 2025 Annual Meeting, emphasizing a vision of 'Sustainable Abundance' and future transformational growth.

SelectQuote, Inc. has filed a definitive proxy statement with the SEC, indicating an upcoming shareholder meeting.

ResMed Inc. announces its 2025 Annual Meeting of Stockholders, outlining proposals including director elections, auditor ratification, executive compensation, and incentive plan amendments.

Jack Henry & Associates, Inc. submitted definitive additional materials for its proxy statement to the SEC.

Adtalem Global Education Inc. announced its 2025 Annual Meeting of Shareholders will be held virtually on November 12, 2025, to vote on director elections, auditor ratification, and executive compensation.

Coherent Corp. achieved record full-year revenue of $5.81 billion in fiscal 2025, driven by a strategic refocus on AI datacenters, communications, and industrial markets, alongside significant governance and leadership enhancements.

ReposiTrak, Inc. announced its 2025 Annual Meeting of Shareholders to be held on November 19, 2025, focusing on director elections, executive compensation, and auditor ratification.

Super League Enterprise, Inc. is seeking shareholder approval for multiple capital raising initiatives, including a $20 million PIPE financing and debt-to-equity conversions, to address Nasdaq listing compliance and fund operations.

SelectQuote, Inc. announces robust fiscal year 2025 financial results, including significant revenue growth and a strategic capital raise, ahead of its 2025 Annual Meeting of Stockholders.

Jack Henry & Associates, Inc. announces its 2025 Annual Meeting of Stockholders to address director elections, executive compensation, a new equity incentive plan, and a shareholder proposal.

Adtalem Global Education reported exceptional FY25 financial and operational results, surpassing growth targets and strengthening its position as a leading healthcare educator.

ResMed reports strong fiscal year 2025 financial performance, driven by innovation and digital health expansion, while proposing key governance updates and board changes.

RYVYL Inc. schedules its 2025 Annual Meeting to address Nasdaq minimum bid price non-compliance with a proposed reverse stock split and seeks to increase authorized shares for future financing and strategic growth.

Broadridge Financial Solutions, Inc. has filed a definitive proxy statement with the SEC.

Professional Diversity Network, Inc. has secured up to $20 million in new financing and increased its authorized share capital, actions approved by majority shareholders but carrying significant dilution risks.

FutureFuel Corp. announced its Annual Meeting of Shareholders on November 11, 2025, to elect two directors and ratify Grant Thornton LLP as its independent auditor.

A-Mark Precious Metals, Inc. announces its 2025 Annual Meeting of Stockholders to elect directors, approve executive compensation, and ratify auditors, following a fiscal year marked by strategic acquisitions despite lower pre-tax profits.